Author: Weehuizen, J.M.; Hoepelman, A.I.M.
Title: An open label cluster randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVIDâ€19 (ARCHAIC) – Protocol publication Cord-id: ewfjifg0 Document date: 2020_5_31
ID: ewfjifg0
Snippet: Chloroquine (CQ) and hydroxychloroquine (HCQ) were both employed in the treatment of COVIDâ€19 in China. Based on unpublished anecdotal positive results in China, CQ is now implemented in China and the Netherlands in moderate to severe COVIDâ€19.
Document: Chloroquine (CQ) and hydroxychloroquine (HCQ) were both employed in the treatment of COVIDâ€19 in China. Based on unpublished anecdotal positive results in China, CQ is now implemented in China and the Netherlands in moderate to severe COVIDâ€19.
Search related documents:
Co phrase search for related documents- absolute risk reduction and loading dose: 1, 2
- active malignancy and admission rate: 1, 2
- active malignancy and loading dose: 1
- active malignancy and lung disease: 1, 2, 3
- additional 10 and admission rate: 1
- additional 10 and loading dose: 1, 2
Co phrase search for related documents, hyperlinks ordered by date